The company says the system can benefit pharmaceutical and biotech firms seeking rapid feedback on drug candidates or genome editing.
SAN DIEGO, Sept. 3, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) today announced the launch of Illumina Protein Prep, an assay introducing superior performance for next-generation sequencing (NGS ...
Illumina is launching a new informatics and artificial intelligence software business aimed at drug developers, with the goal of digesting large-scale DNA sequencing and multi-omics data. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback